February 4, 2012
| eCliniqua > News Briefs - July 28, 2008


News Briefs - July 28, 2008



PHT Corp. announced that its LogPad ePRO system is now available on the Windows Mobile platform as well as the Palm operating system. This expands PHT’s portfolio of eDiary devices by adding the Hewlett-Packard iPAQ 210, a slim, wireless handheld device with a high-resolution 4-inch color touch screen. It provides PHT customers and users with a range of benefits, including trustworthy SimpleSend telecommunication options and the ability to support many fonts and languages in global trials. Read the press release.

Medidata Solutions introduced the latest enhancement to its electronic data capture (EDC), management and reporting system, Medidata Rave – the Dynamic Tabulation Engine. This new feature expands Rave’s data-reporting capabilities and further increases the ease and speed at which clinical data can be made available for analysis, reporting and regulatory submissions in sponsor-specific or standards-based formats as they evolve, such as Study Data Tabulation Model (SDTM). Read the press release.

ProTrials Research Inc. has been selected by the Silicon Valley/San Jose Business Journal as one of the area’s Top 50 Women-Owned Businesses for 2008. ProTrials is the only clinical research organization (CROs) to make the Silicon Valley/San Jose Business Journal top 50 and is one of only a handful of women-owned and operated CROs worldwide.  It recently attained certification by the Women’s Business Enterprise National Council, an elite group of women-owned and operated businesses. Read the press release.

At the DIA annual meeting in June, Quanticate introduced itself to the industry as a single entity comprised of two companies: Statwood and Oxford Pharmaceutical Sciences. The integration takes place after five years of collaboration. The company set up its first U.S. operation in Boston in July 2007, and the launch of Quanticate represents the first step in plans to expand the company’s capabilities and presence in the North American market. Read the press release.

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .